Nuclear factor-kappaB expression as a novel marker of radioresistance in early-stage laryngeal cancer. (Q53362111)

13 May 2018

title

Nuclear factor-kappaB expression as a novel marker of radioresistance in early-stage laryngeal cancer. (English)

1 reference

13 May 2018

0 references

Kenji Yoshida

1

1 reference

13 May 2018

Ryohei Sasaki

2

1 reference

13 May 2018

Hideki Nishimura

3

1 reference

13 May 2018

Yoshiaki Okamoto

4

1 reference

13 May 2018

Yoko Suzuki

5

1 reference

13 May 2018

Tetsuya Kawabe

6

1 reference

13 May 2018

Miki Saito

7

1 reference

13 May 2018

Naoki Otsuki

8

1 reference

13 May 2018

Yoshitake Hayashi

9

1 reference

13 May 2018

Toshinori Soejima

10

1 reference

13 May 2018

Kenichi Nibu

11

1 reference

13 May 2018

Kazuro Sugimura

12

1 reference

13 May 2018

publication date

1 May 2010

1 reference

13 May 2018

published in

Head & Neck

1 reference

13 May 2018

volume

32

1 reference

13 May 2018

issue

5

1 reference

13 May 2018

page(s)

646-655

1 reference

13 May 2018

Multidisciplinary management of laryngeal carcinoma

cites work

1 reference

Comparative voice results after laser resection or irradiation of T1 vocal cord carcinoma

21 January 2018

1 reference

Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment.

21 January 2018

1 reference

Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy

21 January 2018

1 reference

Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.

21 January 2018

1 reference

21 January 2018

1 reference

7 January 2021

Carcinoma of the subglottic larynx

1 reference

7 January 2021

Management of T1-T2 glottic carcinomas

1 reference

7 January 2021

Comparison of surgery and radiotherapy in T1 and T2 glottic carcinomas

1 reference

7 January 2021

Factors associated with recurrence and voice quality following radiation therapy for T1 and T2 glottic carcinomas

1 reference

7 January 2021

Voice quality after treatment for T1a glottic carcinoma--radiotherapy versus laser cordectomy

1 reference

7 January 2021

American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer

1 reference

7 January 2021

Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx

1 reference

7 January 2021

Results of radiation therapy in early glottic carcinoma: multivariate analysis of prognostic and radiation therapy variables

1 reference

7 January 2021

Bcl-2 expression predicts radiotherapy failure in laryngeal cancer

1 reference

7 January 2021

Prognostic significance of EGF receptor expression in early glottic cancer

1 reference

7 January 2021

Prognostic significance of vascular endothelial growth factor protein levels in T1-2 N0 laryngeal cancer treated with primary radiation therapy

1 reference

7 January 2021

Radioresistant laryngeal cancer: beyond the TNM stage

1 reference

7 January 2021

Nuclear factor-kappaB: the enemy within

1 reference

7 January 2021

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

1 reference

7 January 2021

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

7 January 2021

NF-kappaB in cancer: from innocent bystander to major culprit

1 reference

7 January 2021

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

1 reference

7 January 2021

Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma

1 reference

7 January 2021

Control of lymphocyte development by nuclear factor-kappaB.

1 reference

7 January 2021

Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence

1 reference

7 January 2021

Overexpression of Bcl-2 in squamous cell carcinoma of the larynx: a marker of radioresistance.

1 reference

7 January 2021

Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy.

1 reference

7 January 2021

Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis

1 reference

7 January 2021

Radiotherapy in T1 laryngeal cancer: prognostic factors for locoregional control and survival, uni- and multivariate analysis

1 reference

7 January 2021

Ionizing radiation induces expression and binding activity of the nuclear factor kappa B

1 reference

7 January 2021

Nuclear factor-kappaB and manganese superoxide dismutase mediate adaptive radioresistance in low-dose irradiated mouse skin epithelial cells.

1 reference

7 January 2021

NF-kappa B-mediated adaptive resistance to ionizing radiation

1 reference

7 January 2021

Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma

1 reference

7 January 2021

Activation of nuclear factor kappaB In vivo selectively protects the murine small intestine against ionizing radiation-induced damage.

1 reference

7 January 2021

IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium

1 reference

7 January 2021

The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.21239

1 reference

13 May 2018

1 reference

13 May 2018